Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 809-816, August 2000

Iron stores and coronary artery disease:

A clinical application of a method to incorporate measurement error of the exposure in a logistic regression model

  • Louise Pilote

      Affiliations

    • Division of Clinical Epidemiology, The Montreal General Hospital Research Institute, Montreal, Quebec, Canada
    • Corresponding Author InformationCorresponding author. Division of Clinical Epidemiology, L-10 416, Montreal General Hospital, McGill University, 1650 Cedar Ave. Montreal, (QC), H3G 1A4, Canada. Tel: 514–937-6011, ext. 4722; Fax: 514–934-8293
  • ,
  • Lawrence Joseph

      Affiliations

    • Division of Clinical Epidemiology, The Montreal General Hospital Research Institute, Montreal, Quebec, Canada
  • ,
  • Patrick Bélisle

      Affiliations

    • Division of Clinical Epidemiology, The Montreal General Hospital Research Institute, Montreal, Quebec, Canada
  • ,
  • Killian Robinson

      Affiliations

    • The Cleveland Clinic Foundation, Cleveland, OH, USA
  • ,
  • Frederic Van Lente

      Affiliations

    • The Cleveland Clinic Foundation, Cleveland, OH, USA
  • ,
  • Ira B Tager

      Affiliations

    • Division of Public Health Biology & Epidemiology, School of Public Health University of California at Berkeley, Berkeley, CA, USA

Received 3 November 1999; accepted 22 December 1999.

Abstract 

Rates of coronary artery disease (CAD) increase sharply after menopause. We examined the hypotheses that high iron stores, as measured by plasma ferritin levels, are a risk factor for CAD and that the increase in iron stores after menopause is at least in part responsible for the rise in CAD in women. We also investigated measurement error of plasma ferritin using a Bayesian conditional independence model and incorporated it into the estimation of the odds ratio (OR) for males. Cases had ⩾1 coronary artery stenosis ⩾70%. Controls had no visible coronary lesions on angiography. The median plasma ferritin level was 48 mg/L (interquartile range: 28 to 86) among 244 cases and 45 mg/l (24 to 85) among 140 controls. The multivariate analyses among females, males, and females and males combined did not support an association between plasma ferritin levels and CAD (OR for one unit change in log ferritin 1.01, 95% CI 0.71–1.44, OR 0.95, 95% CI 0.66–1.37 and OR 0.95, 95% CI 0.75–1.21, respectively). Accounting for the measurement error of ferritin in males slightly improved the precision of the estimate of the OR but did not unmask an association (OR: 0.94, 95% CI 0.69–1.30). We conclude that high ferritin levels before or after menopause are not associated with CAD. Measurement error might be considered in situations where a one-time measurement is assumed to be representative of long-term exposure.

Keywords:  Ferritin, Coronary artery disease, Menopause, Measurement error

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0895-4356(99)00234-6

Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 809-816, August 2000